Overview

Gender

male

Jean-Luc Bélingard has served as a director of the Company since April 28, 1995. Since 2011, Jean-Luc Bélingard has been Chairman of bioMérieux, the worldwide leader of the IVD microbiology segment. Jean-Luc Bélingard also served as Chief Executive Officer of bioMérieux from July 2011 to April 2014. Jean-Luc Bélingard retired as Chairman and Chief Executive Officer of Ipsen SA, a diversified French health care holding company, on November 22, 2010. He had served in that position since 2001. Prior to this position, Jean-Luc Bélingard was Chief Executive Officer from 1999 to 2001 of bioMérieux-Pierre Fabre, a diversified French health care holding company, where his responsibilities included the management of that company’s worldwide pharmaceutical and cosmetic business. Jean-Luc Bélingard is also a director of Stallergenes (France) and of Lupin Limited since October 27, 2015. Jean-Luc Bélingard was also a director of Celera Corporation, a former division of Applera Corporation, from May 2008 to May 2010. Jean-Luc Bélingard served as a director and member of the Audit Committee of Nicox (France) from December 2002 to August 2010. Jean-Luc Bélingard was a director of Applera Corporation, Norwalk, Connecticut from 1993 to June 2008. From 1990 to 1999, Jean-Luc Bélingard was CEO of Roche Diagnostics and a member of the Hoffman La Roche group Executive Committee. Jean-Luc Belingard’s long tenure at Roche, Ipsen and BioMérieux demonstrates his valuable business, leadership and management experience, including leading a large organization with global operations. He brings a strong strategic and operational background to the Company’s Board. He also brings an important international perspective to the Board’s deliberations. Jean-Luc Bélingard has extensive corporate governance experience through his service on other public company boards.